Galactomannan detection in computerized tomography-based broncho-alveolar lavage fluid and serum in haematological patients at risk for invasive pulmonary aspergillosis.
about
Galactomannan detection for invasive aspergillosis in immunocompromised patientsGalactomannan detection for invasive aspergillosis in immunocompromized patientsEvaluation of PCR on bronchoalveolar lavage fluid for diagnosis of invasive aspergillosis: a bivariate metaanalysis and systematic reviewDiagnosis and antimicrobial therapy of lung infiltrates in febrile neutropenic patients (allogeneic SCT excluded): updated guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO).Fungal diagnostics in pneumoniaSystematic review and meta-analysis of detecting galactomannan in bronchoalveolar lavage fluid for diagnosing invasive aspergillosisPractice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America.Characterization and comparison of galactomannan enzyme immunoassay and quantitative real-time PCR assay for detection of Aspergillus fumigatus in bronchoalveolar lavage fluid from experimental invasive pulmonary aspergillosis.Clinical utility and development of biomarkers in invasive aspergillosis.Biomarkers for invasive aspergillosis: the challenges continue.How to treat severe infections in critically ill neutropenic patients?Diagnosis of invasive aspergillosis by a commercial real-time PCR assay for Aspergillus DNA in bronchoalveolar lavage fluid samples from high-risk patients compared to a galactomannan enzyme immunoassay.Detection and measurement of fungal burden in a guinea pig model of invasive pulmonary aspergillosis by novel quantitative nested real-time PCR compared with galactomannan and (1,3)-β-D-glucan detectionChoices aplenty: antifungal prophylaxis in hematopoietic stem cell transplant recipients.Galactomannan and Zymosan Block the Epinephrine-Induced Particle Transport in Tracheal Epithelium.Detection of galactomannan in bronchoalveolar lavage fluid samples of patients at risk for invasive pulmonary aspergillosis: analytical and clinical validity.Utility of Aspergillus antigen detection in specimens other than serum specimens.Fungal infections in bone marrow transplant recipients.Antigen detection, serology, and molecular diagnosis of invasive mycoses in the immunocompromised host.Strategies to enhance immune function in hematopoietic transplantation recipients who have fungal infections.Diagnostic methods for invasive fungal diseases in patients with hematologic malignanciesFungal pneumonia due to molds in patients with hematological malignancies.Galactomannan antigen detection in the diagnosis of invasive aspergillosis.Advances in the serological diagnosis of invasive Aspergillus infections in patients with haematological disorders.Laboratory diagnosis of invasive aspergillosis: from diagnosis to prediction of outcomeChapter 1: laboratory diagnosis of pulmonary mycoses.Aspergillus galactomannan enzyme immunoassay and quantitative PCR for diagnosis of invasive aspergillosis with bronchoalveolar lavage fluid.Antifungal prophylaxis and treatment in patients with hematological malignancies.Design issues in a randomized controlled trial of a pre-emptive versus empiric antifungal strategy for invasive aspergillosis in patients with high-risk hematologic malignancies.Combined use of nonculture-based lab techniques in the diagnosis and management of critically ill patients with invasive fungal infections.Diagnosing invasive fungal diseases - limitations of microbiological diagnostic methods.Utility of bronchoalveolar lavage fluid galactomannan alone or in combination with PCR for the diagnosis of invasive aspergillosis in adult hematology patients: a systematic review and meta-analysis.Non-cultural methods for the diagnosis of invasive fungal disease.The use of biomarkers and molecular methods for the earlier diagnosis of invasive aspergillosis in immunocompromised patients.Effect of involved Aspergillus species on galactomannan in bronchoalveolar lavage of patients with invasive aspergillosis.Performance characteristics of the platelia Aspergillus enzyme immunoassay for detection of Aspergillus galactomannan antigen in bronchoalveolar lavage fluidComparative evaluation of galactomannan test with bronchoalveolar lavage and serum for the diagnosis of invasive aspergillosis in patients with hematological malignancies.Sensitivity of galactomannan enzyme immunoassay for diagnosing breakthrough invasive aspergillosis under antifungal prophylaxis and empirical therapy.False-positive serum and bronchoalveolar lavage Aspergillus galactomannan assays caused by different antibiotics.Aspergillus colonization in patients with bronchogenic carcinoma.
P2860
Q24186895-A52E6B35-C1D3-40EB-877B-092BFB62CA3CQ24240734-2FDB15DD-257B-456D-8486-17FC9EBAFB9CQ26859024-C28692FF-BB7D-4A30-BC24-73AD5F1C946CQ30608976-08974138-A879-452D-92B0-C76F43A7564FQ34153565-DF66AE67-C368-44B3-B116-12673DD51383Q34385038-A8629F57-66A5-43D1-8EDC-DFFF041B1F4EQ34532546-24B8EA3F-42A4-4F72-A4CF-98FAA803F000Q34719835-A78D09D3-6B72-4AD6-B42D-0DBD4CB89930Q35049005-7CC6836C-CC92-4C8D-AB68-6BAA210866D5Q35142428-5752A1D2-C70E-4363-8280-CF2F47BEE4D4Q35457899-9F1A3665-1050-4AE1-88F6-B13DCB0D9DA6Q35599066-A4A3EB88-A717-40B1-B6D3-1DA4C2051B70Q35806998-4E913E77-252A-4BD2-9EDB-C0E5934F83EFQ35833407-DE5115E0-E052-45CC-BBBA-6B5B7C0FAA04Q35842281-A3B62F90-7268-4D1B-98E9-D518A4BD59F4Q35867884-CD75F8E0-937A-49BD-81DB-64E5279D18FAQ35951605-DE8B7617-489C-47D9-8483-5A54CBC94D64Q36382582-0F885CBA-2786-4305-9AC3-597EEA1C70E0Q36567799-6C182281-814E-4EAA-9FCD-8168F7949766Q36568458-E4B46CE3-41A9-4855-BE0A-2A775A8AD045Q36584898-2333FB48-822C-464E-A6DB-09ABC9D7237DQ36616182-74100DAD-61BE-44BF-A4D6-6139207466C1Q36691715-A567306D-B654-4F7C-A0C9-51080B623DBAQ36774247-30A8529C-6F78-4FE3-A2AF-0878E49AB879Q37287794-1723ECC6-F6DC-4FEE-9B0E-1B82CBE22497Q37612886-36AA5A09-9673-45BE-B9B0-2A74358D5606Q37702655-A3F94DE6-8A54-4E93-A220-C7AC6B1CD1D3Q37727168-C0EE096F-2F0F-420F-8FEE-20338B143A72Q37833638-2FFEB31E-53E5-4DBF-A6B0-5CB43E0EE02EQ38067507-39BCF213-16C0-41B2-B089-3D9DD5A2825EQ38088858-4D82550C-4589-4CB9-9EB3-568F951E8396Q38116964-596F292F-06D4-4EE6-908C-71D8E1165494Q38266817-A08CDB6B-53AD-45B8-8C5D-EB9D6E6EB22EQ38508539-C2A4DC10-994E-4E73-A596-D64E746490A6Q40141118-BDA34876-81D9-4DC2-94FF-98436F46AA36Q41368785-8B70E85B-DD3A-446D-BFC5-37A44AE72E6BQ41649222-50F02EC8-C1AC-4512-AADB-6B5162557018Q42273814-289414F9-E49F-441E-A779-59AF43BDFBA2Q43146182-B49C29C8-1D72-4426-AF0F-4EBD332E2A0BQ43733196-8DB05AC5-3456-4A54-96C2-C56D2E963CB8
P2860
Galactomannan detection in computerized tomography-based broncho-alveolar lavage fluid and serum in haematological patients at risk for invasive pulmonary aspergillosis.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Galactomannan detection in com ...... asive pulmonary aspergillosis.
@en
Galactomannan detection in com ...... asive pulmonary aspergillosis.
@nl
type
label
Galactomannan detection in com ...... asive pulmonary aspergillosis.
@en
Galactomannan detection in com ...... asive pulmonary aspergillosis.
@nl
prefLabel
Galactomannan detection in com ...... asive pulmonary aspergillosis.
@en
Galactomannan detection in com ...... asive pulmonary aspergillosis.
@nl
P2093
P2860
P1476
Galactomannan detection in com ...... asive pulmonary aspergillosis.
@en
P2093
Cindy Van Der Schee
Elly J Lugtenburg
Henk C Hoogsteden
Jan J Cornelissen
Martin J Becker
Siem De Marie
P2860
P304
P356
10.1046/J.1365-2141.2003.04308.X
P407
P577
2003-05-01T00:00:00Z